Friday, June 12, 2026
🇺🇸 FDA

pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia

BEONE MEDICINES AUS

BEONE MEDICINES AUS PTY LTD

BEONE MEDICINES AUS clinical programs — 122 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
2010
Employees
3,177
Programs
122
Drugs
63
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

BEONE MEDICINES AUS projects

122 ClinicalTrials.gov programs sponsored by BEONE MEDICINES AUS.

BEONE MEDICINES AUS has 122 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

122 programs

Clinical programs

Page 1 of 3

  1. BGB-11417 for Previously Untreated Chronic Lymphocytic Leukemia

    BEONE MEDICINES AUS PTY LTD

    Previously Untreated Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  2. BGB-11417-302

    BEONE MEDICINES AUS PTY LTD

    relapsed or refractory mantle cell lymphoma (R/R MCL)

    phase 3 small molecule active

    1 trial

  3. BGB-11417-303CLL-RR1

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  4. BGB-11417-304

    BEONE MEDICINES AUS PTY LTD

    treatment-naive Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  5. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    CLL

    phase 3 small molecule active

    1 trial

  6. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    2 trials

  7. BGB-16673-302

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphotic leukemia and Small Lymphocytic lymphoma

    phase 3 small molecule active

    1 trial

  8. BGB-16673-304

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)

    phase 3 small molecule active

    1 trial

  9. BGB-3111-304

    BEONE MEDICINES AUS PTY LTD

    Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  10. BGB-3111-306

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 3 small molecule active

    1 trial

  11. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    HR+/HER2- Breast Cancer

    phase 3 small molecule active

    1 trial

  12. BGB-A317-290-LTE1

    BEONE MEDICINES AUS PTY LTD

    Solid tumors and hamatological malignancies

    phase 3 small molecule active

    1 trial

  13. BGB-A317-316

    BEONE MEDICINES AUS PTY LTD

    Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

    phase 3 small molecule active

    1 trial

  14. Pamiparib capsule

    BEONE MEDICINES AUS PTY LTD

    Ovarian Cancer

    phase 3 small molecule active

    1 trial

  15. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    4 trials

  16. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    CLL

    phase 3 small molecule active

    1 trial

  17. Sonrotoclax

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 3 small molecule active

    1 trial

  18. Subcutaneous Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Metastatic Gastric Adenocarcinoma

    phase 3 small molecule active

    1 trial

  19. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Non Small Cell Lung Cancer

    phase 3 small molecule active

    4 trials

  20. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Classical Hodgkin Lymphoma

    phase 3 small molecule terminated

    1 trial

  21. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Malignancies

    phase 3 small molecule active

    1 trial

  22. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Urothelial Carcinoma

    phase 3 small molecule active

    1 trial

  23. Tislelizumab

    BEONE MEDICINES AUS PTY LTD

    Esophageal Squamous Cell Carcinoma (ESCC)

    phase 3 small molecule completed

    1 trial

  24. Zanidatamab

    BEONE MEDICINES AUS PTY LTD

    Gastric Neoplasms

    phase 3 small molecule active

    1 trial

  25. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    B-cell Malignancies

    phase 3 small molecule active

    1 trial

  26. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    2 trials

  27. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Primary Membranous Nephropathy

    phase 3 small molecule active

    1 trial

  28. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    B-cell malignancies

    phase 3 small molecule active

    1 trial

  29. Zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  30. zanubrutinib

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma; Non-Hodgkin Lymphoma

    phase 3 small molecule active

    1 trial

  31. Atezolizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Liver Cancers

    phase 2 small molecule active

    1 trial

  32. BFH-NCRTPD

    BEONE MEDICINES AUS PTY LTD

    Colorectal Neoplasms

    phase 2 other active

    1 trial

  33. BGB-10188

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 2 small molecule completed

    1 trial

  34. BGB-11417

    BEONE MEDICINES AUS PTY LTD

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  35. BGB-11417

    BEONE MEDICINES AUS PTY LTD

    Leukemia

    phase 2 small molecule active

    1 trial

  36. BGB-11417-103

    BEONE MEDICINES AUS PTY LTD

    Myeloid malignancies (acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN.

    phase 2 small molecule active

    1 trial

  37. BGB-11417-105

    BEONE MEDICINES AUS PTY LTD

    relapsed or refractory multiple myeloma

    phase 2 small molecule active

    1 trial

  38. BGB-11417-108

    BEONE MEDICINES AUS PTY LTD

    previously untreated chronic lymphocytic leukemia (CLL)

    phase 2 small molecule active

    1 trial

  39. BGB-11417-203

    BEONE MEDICINES AUS PTY LTD

    previously untreated WM, Relapsed/Refractory Waldenström’s Macroglobulinemia

    phase 2 small molecule active

    1 trial

  40. BGB-11417-204

    BEONE MEDICINES AUS PTY LTD

    Previously Untreated Chronic Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

  41. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    B-cell Malignancy

    phase 2 small molecule active

    3 trials

  42. BGB-16673-104

    BEONE MEDICINES AUS PTY LTD

    Relapsed or Refractory B-Cell Malignancies

    phase 2 small molecule active

    1 trial

  43. BGB-45035

    BEONE MEDICINES AUS PTY LTD

    Rheumatoid Arthritis

    phase 2 small molecule active

    1 trial

  44. BGB-A445

    BEONE MEDICINES AUS PTY LTD

    Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  45. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    B Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  46. Blinatumomab

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  47. CCRT with Maintenance Tislelizumab and Metronomic Capecitabine

    BEONE MEDICINES AUS PTY LTD

    Nasopharyngeal Carcinoma

    phase 2 other active

    1 trial

  48. Cyclophosphamide

    BEONE MEDICINES AUS PTY LTD

    Recurrent Transformed Chronic Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does BEONE MEDICINES AUS have?

122 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.